Profile of physical status and gene variation of human papillomavirus 58 genome in cervical cancer

Journal of General Virology

Volumn 90, Issue 5, 2009, Pages 1229-1237

  Wu, En Qi ^a,b   Zha, Xiao ^b   Yu, Xiang Hui ^a   Zhang, Guo Nan ^b   Wu, Yong Ge ^a   Fan, Ying ^b   Ren, Yuan ^b   Kong, Ling Qian ^a   Kong, Wei ^a  

^a JILIN UNIVERSITY   (China)

^b SICHUAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CANCER TISSUE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; GENE EXPRESSION PROFILING; GENE MAPPING; GENE SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 58; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS GENOME; ALPHAPAPILLOMAVIRUS; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 58;

VIRUS DNA;

ALPHAPAPILLOMAVIRUS; CHINA; DNA, VIRAL; FEMALE; GENETIC VARIATION; GENOME, VIRAL; HUMANS; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 67449088024     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.008227-0     Document Type: Article

References (35)

1. Androphy, E. J., Lowy, D. R. & Schiller, J. T. (1987). Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 325, 70-73.
2. Arias-Pulido, H., Peyton, C. L., Joste, N. E., Vargas, H. & Wheeler, C. M. (2006). Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44, 1755-1762.
3. Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. & Shah, K. V. (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55, 244-265.
4. Calleja-Macias, I. E., Villa, L. L., Prado, J. C., Kalantari, M., Allan, B., Williamson, A. L., Chung, L. P., Collins, R. J., Zuna, R. E. & other authors (2005). Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol 79, 13630-13640.
5. Camara, G. N., Cerqueira, D. M., Oliveira, A. P., Silva, E. O., Carvalho, L. G. & Martins, C. R. (2003). Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Mem Inst Oswaldo Cruz 98, 879-883.
6. Cerqueira, D. M., Camara, G. N. D., da Cruz, M. R., Silva, E. O., Brigido, M. D., Carvalho, L. G. D. & Martins, C. R. F. (2003). Variants of human papillomavirus types 53, 58 and 66 identified in Central Brazil. Virus Genes 26, 83-87.
7. Chan, P. K., Lam, C. W., Cheung, T. H., Li, W. W., Lo, K. W., Chan, M. Y., Cheung, J. L. & Cheng, A. F. (2002). Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst 94, 1249-1253.
8. Chan, P. K., Cheung, J. L., Cheung, T. H., Lo, K. W., Yim, S. F., Siu, S. S. & Tang, J. W. (2007). Profile of viral load, integration, and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia. J Infect Dis 196, 868-875.
9. Chan, S. Y., Delius, H., Halpern, A. L. & Bernard, H. U. (1995). Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 69, 3074-3083.
10. Chen, C. A., Liu, C. Y., Chou, H. H., Chou, C. Y., Ho, C. M., Twu, N. F., Kan, Y. Y., Chuang, M. H., Chu, T. Y. & Hsieh, C. Y. (2006). The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group Study. Int J Gynecol Cancer 16, 1801-1808.
11. Chen, Z., Terai, M., Fu, L., Herrero, R., DeSalle, R. & Burk, R. D. (2005). Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 79, 7014-7023.
12. Giannoudis, A. & Herrington, C. S. (2001). Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193, 295-302.
13. Gonzalez-Losa Mdel, R., Rosado-Lopez, I., Valdez-Gonzalez, N. & Puerto-Solis, M. (2004). High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. J Clin Virol 29, 202-205.
14. Hegde, R. S., Grossman, S. R., Laimins, L. A. & Sigler, P. B. (1992). Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359, 505-512.
15. Hildesheim, A., Schiffman, M., Bromley, C., Wacholder, S., Herrero, R., Rodriguez, A., Bratti, M. C., Sherman, M. E., Scarpidis, U. & other authors (2001). Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93, 315-318.
16. Ho, C. M., Chien, T. Y., Huang, S. H., Lee, B. H. & Chang, S. F. (2006). Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol Oncol 102, 54-60.
17. Huang, S., Afonina, I., Miller, B. A. & Beckmann, A. M. (1997). Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 70, 408-411.
18. Jeon, S. & Lambert, P. F. (1995). Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 92, 1654-1658.
19. Kjaer, S. K., van den Brule, A. J., Bock, J. E., Poll, P. A., Engholm, G., Sherman, M. E., Walboomers, J. M. & Meijer, C. J. (1996). Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 65, 601-606.
20. Kurvinen, K., Yliskoski, M., Saarikoski, S., Syrjanen, K. & Syrjanen, S. (2000). Variants of the long control region of human papillomavirus type 16. Eur J Cancer 36, 1402-1410.
21. Lewis, H., Webster, K., Sanchez-Perez, A. M. & Gaston, K. (1999). Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein. J Gen Virol 80, 2087-2096.
22. Lizano, M., Berumen, J., Guido, M. C., Casas, L. & Garcia-Carranca, A. (1997). Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 89, 1227-1231.
23. Matsumoto, K., Yoshikawa, H., Nakagawa, S., Tang, X., Yasugi, T., Kawana, K., Sekiya, S., Hirai, Y., Kukimoto, I. & other authors (2000). Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 156, 159-165.
24. Munoz, N. (2000). Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 19, 1-5.
25. Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V., Snijders, P. J. & Meijer, C. J. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518-527.
26. Qiu, A. D., Wu, E. Q., Yu, X. H., Jiang, C. L., Jin, Y. H., Wu, Y. G., Chen, Y., Chen, Y., Shan, Y. M. & other authors (2007). HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Gynecol Oncol 104, 77-85.
27. Romanczuk, H., Thierry, F. & Howley, P. M. (1990). Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol 64, 2849-2859.
28. Stephen, A. L., Thompson, C. H., Tattersall, M. H., Cossart, Y. E. & Rose, B. R. (2000). Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer 86, 695-701.
29. Stewart, A. C., Eriksson, A. M., Manos, M. M., Munoz, N., Bosch, F. X., Peto, J. & Wheeler, C. M. (1996). Intratype variation in 12 human papillomavirus types: A worldwide perspective. J Virol 70, 3127-3136.
30. Storey, A., Piccini, A., Massimi, P., Bouvard, V. & Banks, L. (1995). Mutations in the human papillomavirus type 16 E2 protein identify a region of the protein involved in binding to E1 protein. J Gen Virol 76, 819-826.
31. Thierry, F. & Howley, P. M. (1991). Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biol 3, 90-100.
32. Tornesello, M. L., Duraturo, M. L., Buonaguro, L., Vallefuoco, G., Piccoli, R., Palmieri, S. & Buonaguro, F. M. (2007). Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer 2, 1.
33. Villa, L. L., Sichero, L., Rahal, P., Caballero, O., Ferenczy, A., Rohan, T. & Franco, E. L. (2000). Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81, 2959-2968.
34. Wheeler, C. M., Yamada, T., Hildesheim, A. & Jenison, S. A. (1997). Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35, 11-19.
35. Xin, C. Y., Matsumoto, K., Yoshikawa, H., Yasugi, T., Onda, T., Nakagawa, S., Yamada, M., Nozawa, S., Sekiya, S. & other authors (2001). Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett 170, 19-24.